The influence of glyoxalase 1 gene polymorphism on its expression at different stages of breast cancer in Egyptian women
Rehab S. Abdul-Maksoud1, Walid SH. Elsayed2 and Rasha S. Elsayed3
1 Medical Biochemistry Department, Faculty of Medicine, Zagazig University, Egypt
2 Pathology Department, Faculty of Medicine, Zagazig University, Egypt
3 General Surgery Department, Faculty of Medicine, Zagazig University, Egypt
Correspondence:
Rehab S. Abdul-Maksoud, email:
Keywords: breast cancer; gene polymorphism; gene expression; enzymatic activity
Received: November 07, 2017 Accepted: December 22, 2017 Published: December 27, 2017
Abstract
Aim: To assess the association of GLO1 C332C gene polymorphism with breast cancer risk at different stages of the disease and to investigate the effect of this gene polymorphism on its mRNA expression and enzyme activity.
Methods: GLO1 C332C gene polymorphism was analyzed by PCR-RFLP in 100 healthy controls and 200 patients with breast cancer (100 patients with stage I & II and 100 patients with stage III & IV). GLO1 mRNA expression was measured by real time PCR. Serum GLO1 enzyme activity was measured colorimetrically.
Results: GLO1 A allele was associated with increased risk of breast cancer [OR (95%CI)= 2.8(1.9-4.1), P < 0.001]. Its frequency was significantly higher among advanced stages of breast cancer compared with localized tumors (OR (95%CI)= 1.9(1.3-2.9), p < 0.001). GLO1 mRNA expression and enzyme activity were significantly higher in breast cancer patients compared to controls and they were much higher in the advanced stages of the disease (P < 0.001). Carriers of AA genotype showed higher GLO1 expression and enzyme activity compared with carriers of CC genotype.
Conclusion: GLO1 C332C SNP was associated with overexpression of GLO1 mRNA and higher enzyme activity in breast cancer patients suggesting its role in the development of breast cancer and its progression from localized to advanced.
